secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2026-04-27T23:59:59+00:00
Accession:  0001213900-26-048064
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed reduces exercise price of Sabby and Wainwright preferred investment options to $0.80
--------------------------------------------------------------------------------

- Sabby options now exercisable at $0.80 (was $2.436) for up to 2,151,478 shares.
- Wainwright options exercise price reduced to $0.80 from $82.50, $20.75, and $3.2013 for 153,236 shares.
- Amendments signed April 21 and April 24, 2026; announced April 27.
- Lower exercise price could lead to exercise and dilution of existing shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390026048064/0001213900-26-048064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390026048064/ea0287728-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-048064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer